APLS earnings: a negative outcome, -19.6%

On July 31, 2023, Apellis Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -19.6% in the window around the event. It had already run -64.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.